S-Adenosyl-L-methionine tosylate 0321 InChi: InChI=1S/C20H17FN6/c21-16-6-2-1-4-13(16)11-27-20-14(5-3-9-23-20)17(26-27)19-24-10-15(12-7-8-12)18(22)25-19/h1-6

InChi: InChI=1S/C20H17FN6/c21-16-6-2-1-4-13(16)11-27-20-14(5-3-9-23-20)17(26-27)19-24-10-15(12-7-8-12)18(22)25-19/h1-6

PubMed PMID: 29195005

Bucolome is a CYP2C9 inhibitor

anti-inflammatory compound that inhibits PDE4 activity and thereby suppresses the release of TNFalpha

S-Adenosyl-L-methionine tosylate 0321 InChi: InChI=1S/C20H17FN6/c21-16-6-2-1-4-13(16)11-27-20-14(5-3-9-23-20)17(26-27)19-24-10-15(12-7-8-12)18(22)25-19/h1-6S Adenosyl L methionine tosylate (S Adenosyl methionine tosylate) is produced endogenously from methionine and ATP by action of the enzyme methionine adenosyltransferase and is an important orally active methyl group donor. S Adenosyl L methionine tosylate is a dietary supplement with potent antidepressant and analgesic effects, and has the potential for liver disease and osteoarthritis research. Product information Molecular Weight: 570. 64 Formula: